ABVC - ABVC BioPharma, Inc. Quarterly EPS earnings growth
ABVC BioPharma is targeting the global expansion of its portfolio of plant-based treatments for ADHD and depression. The quarterly EPS growth reflects the momentum of this process, where 78.40 shows the current value of the metric. The reliability of the research is guaranteed by strict control over the transportation of biological preparations. Furthermore, ABVC BioPharma minimizes regulatory risks by utilizing a diversified pool of external contractors to conduct clinical trials.
%20Earnings%20per%20share%20growth%20in%20annualized%20terms%20for%20the%20last%20twelve%20months&width=1200&height=400&colorIndex=0&v=mwa76aez.ocr-7cpmfb4&start=20220704&end=20261110&filename=GURU_Markets_-_ABVC_-_ABVC-BioPharma_-_Earnings-per-share-growth-in-annualized-terms-for-the-last-twelve-months "abvcpharma.com (ABVC): Year-over-year earnings per share growth for the last twelve months from 07/04/2022 to 11/10/2026 | 👁️GURU.Markets👁️")
Financial and market metric breakdowns for ABVC BioPharma, Inc (ABVC)
- share price and expert price forecast:
- market capitalization statistics:
- balance sheet net asset value indicators:
- company liabilities and liquidity data:
- earnings and market multiples details:
ABVC - Company Net Income|Projected Future Earnings ABVC BioPharma|ABVC - Business Payback Period|Future Price to Earnings ABVC BioPharma Inc|ABVC - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ABVC BioPharma Inc|ABVC - Profit before deduction of interest, taxes, depreciation and amortization|Net earnings per share (EPS TTM) ABVC BioPharma|ABVC - Earnings per share for the trailing year|Quarterly EPS earnings growth abvcpharma.com|ABVC - Earnings growth in current year|Net earnings per share growth forecast for next year ABVC BioPharma
Fundamental valuation:ABVC BioPharma, Inc. - ABVC
This indicator measures the percentage change in net earnings per share per quarter, allowing investors to filter out market noise and assess the actual profitability dynamics of the business. By analyzing the quarterly growth rate of earnings per share, one can determine the effectiveness of the development of ADHD and depression drugs, as well as the impact of strategic investments on the capitalization of ABVC BioPharma (ABVC).
Main competitors
HLN: Quarterly EPS earnings growth|Kenvue Inc - Year-over-year earnings per one share growth for the last 12 months|VRNA (Verona Pharma Corp) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Jyong Bio MENS|Year-over-year earnings per share growth for the last twelve months Ligand Pharmaceuticals (LGND)|AMRX (amneal.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth PRGO (Perrigo)|Quarterly EPS earnings growth Alvotech S.A. ALVO|Liquidia Technologies - Quarterly EPS earnings growth|GLPG: Year-over-year earnings per share growth for the last twelve months|ANIP (ANI Pharmaceuticals) - Year-over-year net earnings per share growth for the last 12 months|MNKD (mannkindcorp.com) - Year-over-year earnings per share growth for the last twelve months|AMPH (Amphastar Pharmaceuticals, Inc.) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Pacira Pharmaceuticals (PCRX)|Year-over-year net earnings per share growth for the last 12 months SPRY (ARS Pharma)|TBPH (Theravance Corp) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth AQST (Aquestive Therapeutics)|scPharmaceuticals, Inc. - Year-over-year earnings per share growth for the last twelve months|Tectonic - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Tonix Pharma TNXP|sxtchina.com (SXTC) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Eupraxia Pharmaceuticals Inc. (EPRX)|Year-over-year earnings per share growth for the last twelve months BioHarvest Sciences|invizyne.com - Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth ORMP|ENTX (enterabio.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth HYFT (MindWalk)|Quarterly EPS earnings growth Cumberland Corp CPIX|QNTM - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months FGEN (fibrogen.com)|Telomir Pharmaceuticals, Inc. (TELO) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Rani Therapeutics Holdings, Inc.|SNYR (Synergy CHC Corp.) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Rallybio Corp.|Quarterly EPS earnings growth LEXX|Quarterly EPS earnings growth pulmatrix.com (PULM)|Quarterly EPS earnings growth PTHL (Pheton Holdings)|Aptorum Group Ltd - Year-over-year earnings per share growth for the last twelve months|LYRA: Year-over-year net earnings per share growth for the last 12 months|IBO: Year-over-year earnings per share growth for the last twelve months|TNFA: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months cbdMD|Year-over-year earnings per share growth for the last twelve months PainReform|Auris Medical - Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth LIPO|OPTN (OptiNose Corp) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth PIRS (Pieris Pharmaceuticals)|Quarterly EPS earnings growth procapsgroup.com PROC|PTPI - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months QLI (Qilian International Holding Group)|ACELYRIN, Inc. (SLRN) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months TFF Pharmaceuticals, Inc
